Read this somewhere....Besivance? Where's the sizzle?...Let's see..novel anti-biotic not used systemically...novel delivery system..B&L sales effort....PFE sales effort...(they don't get involved unless the product is going to be 100mm)..why else is Pfizer involved unless they plan to buy Bausch & Lomb and then buy back the 6% royalty stream from INSV that is worth about $50-$90 million plus ....what else would you like to know..?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.